Florian Kainzinger

Florian Kainzinger is an experienced professional serving as a member of the advisory board for Selfapy and as a board observer for First Light Diagnostics and PathologyWatch. Florian holds multiple board positions, including member of the board of directors at Inflammatix, Inc., Saladax Biomedical Inc., and Cantourage GmbH. Currently, Florian is a member of the board of directors and advisory board for SphingoTec and Spindiag GmbH, respectively, with extensive experience in managing partnerships at Think.Health Ventures and Think.Health Hygiene Solutions since 2015. Florian's academic background includes a Ph.D. from Charité - Universitätsmedizin Berlin and a Master of Science in Business Administration and Management from the London School of Economics and Political Science and Ludwig-Maximilians Universität München.